FMA
BIO icon

FNY Managed Accounts’s Bio-Rad Laboratories Class A BIO Stock Holding History

FNY Managed Accounts’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-14
Closed -$3K – 620
2017
Q4 		$3K Buy
+14
New +$3.39K ﹤0.01% 381
2016
Q4 		– Sell
-500
Closed -$81.9K – 63
2016
Q3 		$81.9K Buy
+500
New +$75.9K 0.07% 164

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FNY Managed Accounts's BIO Position: Q1 2018 in Review

FNY Managed Accounts sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2018, closing a stake of 14 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in BIO in Q3 2016 and held it in 2 quarters. The position peaked at $81.9K in Q3 2016. 316 funds tracked by Wall St. Rank hold BIO as of Q1 2018.

  • FNY Managed Accounts reported no remaining Bio-Rad Laboratories Class A position as of Q1 2018 after selling out during the quarter.
  • FNY Managed Accounts sold 14 Bio-Rad Laboratories Class A shares in Q1 2018, an estimated $3K.
  • FNY Managed Accounts first reported a position in Bio-Rad Laboratories Class A in Q3 2016 and held it in 2 quarters.
  • FNY Managed Accounts's Bio-Rad Laboratories Class A position peaked at $81.9K in Q3 2016.
  • 316 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.